| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |